Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders |
ChromaDex Corp. (CDXC)
|
Add to portfolio |
|
|
Price: |
$9.04
| | Metrics |
OS: |
75.0
|
M
| |
|
|
Market cap: |
$678
|
M
| |
|
|
Net cash:
|
$26.3
|
M
| |
$0.35
|
per share
|
EV:
|
$652
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-30-17 | Dec-31-16 | Jan-02-16 |
Revenues | 72.1 | 67.4 | 59.3 | 46.3 | 31.6 | 21.2 | 21.7 | 17.9 |
Revenue growth | 6.8% | 13.8% | 28.0% | 46.7% | 48.8% | -2.1% | 21.1% | 16.8% |
Cost of goods sold | 29.3 | 26.0 | 24.0 | 20.5 | 15.5 | 10.7 | 11.3 | 10.4 |
Gross profit | 42.8 | 41.5 | 35.3 | 25.8 | 16.1 | 10.5 | 10.4 | 7.5 |
Gross margin | 59.4% | 61.5% | 59.5% | 55.7% | 50.9% | 49.4% | 48.0% | 42.1% |
Selling, general and administrative | | | | | | | | |
Sales and marketing | 28.3 | 28.4 | 20.9 | 18.2 | 16.5 | 4.5 | 1.6 | 1.5 |
Research and development | 4.8 | 3.8 | 3.4 | 4.4 | 5.5 | 4.0 | 2.5 | 0.9 |
General and administrative | 28.3 | 36.4 | 30.8 | 34.3 | 27.1 | 17.6 | 9.2 | 7.2 |
EBITA | -18.4 | -26.8 | -19.6 | -31.1 | -32.9 | -10.7 | -2.8 | -2.0 |
EBITA margin | -25.6% | -39.8% | -33.1% | -67.1% | -104.4% | -50.5% | -13.0% | -11.3% |
Amortization of intangibles | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 |
EBIT | -18.6 | -27.1 | -19.9 | -31.3 | -33.2 | -10.9 | -2.9 | -2.1 |
EBIT margin | -25.9% | -40.1% | -33.5% | -67.6% | -105.1% | -51.5% | -13.4% | -11.6% |
Pre-tax income | -16.5 | -27.1 | -19.9 | -32.1 | -33.3 | -16.5 | -3.6 | -2.6 |
Income taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -5.2 | 0.0 | 0.0 |
Tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 31.2% | 0.0% | |
Earnings from continuing ops | -16.5 | -27.1 | -19.9 | -32.1 | -33.3 | -16.5 | -3.6 | -2.6 |
Earnings from discontinued ops | | | | | | 5.2 | 0.6 | -0.1 |
Net income | -16.5 | -27.1 | -19.9 | -32.1 | -33.3 | -11.4 | -2.9 | -2.8 |
Net margin | -23.0% | -40.2% | -33.6% | -69.4% | -105.6% | -53.7% | -13.5% | -15.5% |
|
Diluted EPS | ($0.24) | ($0.40) | ($0.33) | ($0.56) | ($0.61) | ($0.37) | ($0.10) | ($0.07) |
Shares outstanding (diluted) | 69.7 | 67.2 | 61.1 | 57.1 | 55.0 | 44.6 | 37.3 | 35.9 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|